When federal regulators last week approved Digene Corp.'s cervical cancer test as a primary screening tool for women over 30, they catapulted what had been a follow-up test into direct competition ...
Digene Corp., a Gaithersburg company that sells DNA-based tests to detect diseases, is jumping into the growing market for drug-research tools that analyze genetic activity. Digene announced yesterday ...
NEW YORK, Jan 12 (Reuters) - Digene Corp's new chief executive officer said on Friday the company could not afford to remain "a one-product company" and would aim to disclose a strategy of moving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results